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Background: Eye development in vertebrates relies on the critical regulation of SOX2 expression. Humans with
mutations in SOX2 often suffer from eye defects including anophthalmia (no eye) and microphthalmia (small eye).
In mice, deletion of Sox2 in optic cup progenitor cells results in loss of neural competence and cell fate conversion
of the neural retina to a non-neurogenic fate, specifically the acquisition of fate associated with progenitors of the
ciliary epithelium. This fate is also promoted with constitutive expression of stabilized β-Catenin in the optic cup,
where the WNT pathway is up-regulated. We addressed whether SOX2 co-ordinates the neurogenic boundary of
the retina through modulating the WNT/β-Catenin pathway by using a genetic approach in the mouse.
Results: Upon deletion of Sox2 in the optic cup, response to WNT signaling was expanded, correlating with loss of
neural competence, cell fate conversion of the neural retina to ciliary epithelium primordium and, in addition,
increased cell cycle time of optic cup progenitors. Removal of Ctnnb1 rescued the cell fate conversion; however,
the loss of neural competence and the proliferation defect resulting from lack of SOX2 were not overcome. Lastly,
central Sox2-deficient optic cup progenitor cells exhibited WNT-independent up-regulation of D-type Cyclins.
Conclusion: We propose two distinct roles for SOX2 in the developing retina. Our findings suggest that SOX2 antagonizes
the WNT pathway to maintain a neurogenic fate and, in contrast, regulates cycling of optic cup progenitors in a
WNT-independent manner. Given that WNT signaling acting upstream of SOX2 has been implicated in the tumorigenicity
of embryonic stem cell-derived retinal progenitor cells, our results distinguish the endogenous role of WNT signaling in
early optic cup patterning and support a WNT-independent role for SOX2 in maintaining retinal progenitor cell proliferation.
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SOX2Background
How neural progenitor cells maintain the ability to gener-
ate neurons over time is a major question in developmen-
tal neurobiology. The eyecup is an ideal tool to address
this question, because it consists of neurogenic and non-
neurogenic structures derived from a common progenitor
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unless otherwise stated.neural plate [1,2]. The eyefield gives rise to the optic
vesicle, which invaginates to form the optic cup (OC)
around embryonic day (E) 10.0 of mouse development [3].
The OC is regionalized along the central-peripheral axis:
the central OC consists of neurogenic retinal progenitor
cells (RPCs) that give rise to the six neuronal and one glial
cell type that make up the neural retina (NR). The periph-
eral OC rim, also known as the ciliary margin (CM), gives
rise to the non-neurogenic epithelium of the iris and cil-
iary body (CB), herein referred to as ciliary epithelium
(CE) (reviewed in [4]). Multipotent progenitor cells at the
central boundary of the CM make a binary cell fate deci-
sion to become NR or CE [5].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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nisms that specify neurogenic versus non-neurogenic fate
in the OC. Canonical WNT signaling, which functions
through its downstream transcriptional effector β-
Catenin, has been identified as a major regulator of CE
fate specification in many species [6-12]. In the chick eye,
WNT/β-Catenin signaling was found to inhibit NR fate
and promote CE fate [7]. In the mouse, a genetic reporter
under the control of β-Catenin/TCF/LEF response ele-
ments showed WNT activity to be concentrated to the
CM [6], and specific ablation of Ctnnb1 in OC progenitor
cells (OCPCs) reduced the size of the CE progenitor cell
pool [8,13]. Conversely, stabilized expression of Ctnnb1 in
mouse OCPCs induced ectopic expression of CE-specific
genes [8]. However, these ectopic CE-like cells did not ex-
press Pax6 or Chx10, two well-known transcriptional reg-
ulators of CE fate, suggesting that there was only a partial
transformation of NR-to-CE upon activation of Ctnnb1.
Unsurprisingly, in light of the above, removing the in-
hibition of WNT signaling also induced CE fate; Foxg1-
null embryos showed expanded WNT activity into the
central OC and ectopic formation of CE positive for
both Pax6 and Chx10, suggesting that near physiological
levels of β-Catenin may be required to generate all the
hallmarks of CE [14]. Thus, precise regulation of the
level of WNT activity is crucial for establishing the
proper boundary between CE and NR, where factors
mediating this function are not known.
SRY (sex determining region Y)-box (SOX) proteins
are known regulators of WNT signaling in several devel-
opmental systems and disease states. SOX2, a member
of the SOXB1 family of transcription factors, is a major
regulator of neural competence in vertebrates [15-17].
Heterozygous mutations in human SOX2 are associated
with anophthalmia (absent eye) and account for 10 to
20% of cases of severe bilateral ocular malformation, in-
cluding microphthalmia (small eye) [18-20] indicating a
defect in OCPC proliferation or survival. In the mouse
OC, SOX2 expression is restricted to the presumptive
NR, and ablation of Sox2 in OCPCs resulted in loss of
neural competence and cell fate conversion of the NR to
CE primordium, accompanied by an increase in WNT
signaling [5]. The genetic relationship between SOX2
and WNT signaling in this context was not investigated.
In addition to eye defects, human patients with SOX2
mutations often have pituitary abnormalities, and WNT
signaling is known to be involved in hypothalamic and pi-
tuitary development. Human SOX2 protein can inhibit β-
Catenin-driven reporter expression in vitro, but several
SOX2 proteins with the identified human mutations can-
not. Therefore, it has been suggested that an inability to
repress WNT/β-Catenin signaling may contribute to the
pathogenesis of SOX2 loss-of-function (LOF) mutations in
human patients [21,22]. In support of this hypothesis, aSOX2 binding site was identified in the Lef1 promoter and
was found to function as a repressor of β-Catenin-
dependent Lef1 expression in primary airway epithelial cells
[23]. Additionally, in osteoblasts, SOX2 was shown to phys-
ically associate with β-Catenin to down-regulate the expres-
sion of many WNT target genes, but the HMG domain
was not required, suggesting that SOX2 may antagonize
WNT signaling via β-Catenin sequestration [24].
The complementary eye phenotypes associated with
Sox2 and Ctnnb1 LOF suggest antagonism between
these two pathways in mammalian OC development. In
lower vertebrates and in RPCs differentiated from in-
duced pluripotent stem cells, these two pathways have
been found to work somewhat synergistically to promote
retinal neural progenitor proliferation [25,26]. These
findings may reflect species-specific differences in the
role of WNT signaling in OC development. Alterna-
tively, WNT signaling may play different roles over de-
velopmental time: constitutive activation of WNT
signaling later in development, in a subset of committed
neural precursors, may have different effects than that of
widespread WNT activation at earlier time points, in un-
committed OCPCs. Given the evidence that SOX2 and
WNT signaling play complex and crucial roles in the eye
development of many species, we chose to dissect the
relationship between these two factors using a genetic
approach in the mouse.
In this study, we investigated the hypothesis that SOX2
antagonizes canonical WNT signaling to maintain neuro-
genic fate in the mouse OC. We present whole-genome
expression arrays comparing wild-type and Sox2-mutant
OCs demonstrating the deregulation of the WNT pathway
and serving as a resource for identifying genes involved in
CE fate and function, with direct relevance to understand-
ing the pathogenesis of diseases associated with the anter-
ior segment. We show that removal of Ctnnb1 from the
Sox2-mutant OC partially rescued the Sox2-mutant
phenotype. Conversely, ectopic activation of the WNT
pathway in Sox2-expressing cells resulted in acquisition of
CE fate following loss of Sox2 expression. Our data pro-
vide evidence that SOX2 antagonizes CE fate via modula-
tion of WNT signaling and highlight a β-Catenin-
independent role for SOX2 to promote proliferation and
prevent aberrant expression of cell cycle regulators in
OCPCs.
Results
Canonical WNT signaling is ectopically activated in
Sox2-mutant optic cups
Ablation of Sox2 in the mouse OC from E10.5 leads to
eventual loss of NR fate and expansion of the non-
neurogenic CE [5]. To determine the molecular mecha-
nisms underlying this phenotype, we performed a whole
genome expression screen of Sox2cond/+;αP0CREiresGFP
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E16.5, when the loss of neural fate is taking place
(Figure 1A). We ran one microarray for each of six pairs of
eyes per genotype, for a total of twelve microarrays. The
complete results from this screen have been deposited in
NCBI’s Gene Expression Omnibus [27] and can be
accessed through the GEO series accession number
GSE46796 (http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE46796). We identified 880 significantly up-
regulated genes and 951 significantly down-regulated
genes in mutant OCs compared with controls (see
Methods). To confirm the efficacy of this screen, we first
verified that transcripts found to change by in situ
hybridization (ISH) [5] behaved as expected by microarrayFigure 1 Genome-wide expression analysis of E16.5 Sox2-mutant opt
ciliary epithelium (CE) primordium genes, and suggests activated WN
undergoing NR-to-CE primordium cell fate conversion were analyzed by m
CE (orange) at the expense of the central OC/prospective NR (blue) in mut
(orange) are consistent with CE function, while those of decreased transcrip
expressed genes suggest activated WNT signaling and perturbed cell cycle
of the screen.(Figure 1C). As anticipated, in mutants compared with
controls, Sox2 was decreased over 4-fold, Hes5, an NR
marker, which was found to be absent in Sox2-ablated
cells, was decreased almost 5-fold, and Chx10, a definitive
marker of OC progenitors at this stage, and which was
shown to be maintained, was not significantly changed.
We then used DAVID analysis software [28,29] to
search for enriched functional terms in each group of
genes and determine if they were consistent with a change
in cell fate. The full list of genes for each enriched func-
tional term for each group is provided in Additional file 1.
Up-regulated genes were enriched for terms associated
with secreted signaling, extracellular matrix, cell adhesion,
organogenesis and the defense response, all of which areic cups (OCs) confirms loss of neural retina (NR) fate, activation of
T signaling. Global changes in gene expression in Sox2-ablated OCs
icroarray. (A) Diagram of expansion of the peripheral OC/prospective
ants compared with controls. (B) Ontologies of increased transcripts
ts (blue) are consistent with NR function. (C) Subsets of aberrantly
. Decreased Hes5 and Sox2, and unchanged Chx10, confirm the validity
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traocular pressure through secretion [30,31] and to pro-
duce proteins of the inner limiting membrane and the
vitreous body [32,33] (Figure 1B). By contrast, down-
regulated genes were enriched for terms associated with
axonogenesis, synaptic development, neuronal differenti-
ation and microtubule cytoskeleton, consistent with the
loss of neurogenic fate observed in mutants. Collectively,
these data confirm that our screen provides a reliable indi-
cation of functional pathways disrupted by Sox2 ablation.
We next queried which signaling pathways were dis-
rupted in Sox2-mutant eyes. Two of the most significantly
affected pathways were canonical WNT signaling and
transforming growth factor beta (TGFβ) signaling, both
known for their involvement in CE fate specification
[7,8,34,35]. We focused further on WNT signaling, given
that SOX2 was shown to antagonize the pathway in the
Xenopus OC [25], and we have observed ectopic expres-
sion of WNT pathway genes, including Lef1, Sfrp2 and
Axin2, in the Sox2-mutant OC at E14.5 [5]. We scanned
our set of significantly changed transcripts for known OC-
specific WNT target genes and identified 13 for which ex-
pression was changed at least 1.47-fold (Figure 1C, orange
bars; Additional file 2) [9,11,12,36,37]. We also confirmed
that Axin2, a well-characterized read-out of WNT signal-
ing, was increased (1.29-fold, P = 0.0155). Collectively,
these data suggest that response to the WNT pathway
was activated upon Sox2 ablation. We thus hypothesized
that SOX2 normally antagonizes canonical WNT signaling
to maintain neurogenic fate in the mouse OC.
Genetic removal of Ctnnb1 does not rescue the
neurogenesis defect of Sox2-mutant retinas
If increased WNT signaling causes loss of neural compe-
tence upon ablation of Sox2, then reduction of WNT ac-
tivity should rescue neurogenesis in Sox2-mutant eyes.
SOX2 protein has been shown to interact directly with
β-Catenin/Ctnnb1, the main transcriptional mediator of
canonical WNT signaling, to inhibit the activation of tar-
get genes in many biological systems [24,38-40]. So to
address this hypothesis, we performed epistasis analysis
using conditional alleles of both Sox2 and Ctnnb1 an
OC-specific Cre. Ctnnb1lox(ex2–6)/+ mice, in which exons
2 to 6 of the Ctnnb1 locus are flanked by loxP sites [41],
were crossed with transgenic mice carrying Chx10CreGFP,
a BAC transgene expressing Cre recombinase in OCPCs
as early as E10.5 [42]. For this experiment, we chose to
use Chx10CreGFP in place of αP0CreiresGFP in order to
avoid differential regulation of the αP0Cre transgene in
the absence of SOX2 and β-Catenin, as previously ob-
served [5,8]. Distinctions between our uses of αP0Creir-
esGFP and Chx10CreGFP are summarized in Table 1.
Ctnnb1lox(ex2–6)/+;Chx10CreGFP mice were crossed with
Sox2cond/+ mice to produce Sox2/Ctnnb1 double-mutantOCPCs. We compared the eyes of Sox2 single-mutants
(Sox2cond/cond;Chx10CreGFP) and Ctnnb1 single-mutants
(Ctnnb1lox(ex2–6)/lox(ex2–6);Chx10CreGFP) with Sox2/Ctnnb1
double-mutants (Sox2cond/cond;Ctnnb1lox(ex2–6)/lox(ex2–6);
Chx10CreGFP) and stage-matched controls (Sox2cond/+;
Ctnnb1lox(ex2–6)/+;Chx10CreGFP).
We first verified that Sox2 and Ctnnb1 were efficiently
ablated with Chx10CreGFP and that co-ablation did not
increase cell death (Additional file 3). In double-mutant
OCs, SOX2 and β-Catenin proteins were absent from
GFP-positive cells, demonstrating that Chx10CreGFP was
able to recombine all floxed alleles in the same nuclei
(Additional file 3D, E versus A, B). Moreover, deletion of
both genes did not increase cell death as assayed by
activated-Caspase 3 staining (Additional file 3C, F).
To test the hypothesis that removal of Ctnnb1 from
Sox2-mutant cells would rescue the loss of neural com-
petence, we examined expression of prospective NR
markers in single-mutant and double-mutant OCs at
E13.5 (Figure 2; Table 2). We first examined expression
of β-Tubulin III, a neuronal marker, to determine
whether neurogenesis was restored in double- mutant
OCs. β-Tubulin III was expressed in the central OC of
controls, marking retinal ganglion cells (RGCs), but was
broadly lost in Sox2 single-mutants and in Sox2/Ctnnb1
double-mutants (Figure 2B and E versus H and K).
RGCs express Sonic Hedgehog (Shh), so to confirm the
observed loss of neurogenesis, we examined Shh expres-
sion in control and mutant eyes. Like β-Tubulin III, Shh
was expressed in the RGC layer of controls (Figure 2C, F,
area between closed arrowheads), but expression was
essentially lost in Sox2 single-mutant and double-mutant
eyes (Figure 2I, L, closed arrowhead indicating residual
Shh in a double-mutant eye correlating with residual
β-Tubulin III expression). Shh expression in the pre-
sumptive eyelids remained unchanged in all genotypes,
confirming the efficacy of the staining (Figure 2C, F, I, L,
white arrowheads).
CyclinD1/Ccnd1 is normally restricted to the central
OC and is often used to mark NR progenitor cells
[8,14]. In wild-type controls and Ctnnb1 single-mutant
eyes, Ccnd1 mRNA was expressed in central neurogenic
progenitor cells. Ccnd1 expression persisted in Sox2
single-mutant OCs despite the loss of NR fate (Figure 2A
and D versus G). Overall, Ccnd1 staining appeared de-
creased in Sox2-ablated cells consistent with the gene
expression results of the microarray analysis, which
showed a 2-fold decrease (P = 0.001). Moreover, removal
of Ctnnb1 from Sox2-mutant OCPCs did not further di-
minish Ccnd1 expression (Figure 2J). In summary, gen-
etic reduction of WNT activation did not restore neural
competence to Sox2-ablated eyes at E13.5, and expres-
sion of Ccnd1 was sustained despite loss of either
pathway.
Table 1 Distinctions between the two optic cup (OC)-specific Cre lines used in this study
CRE line Onset Expression pattern Applications in this study
αP0CREiresGFP E10.5 Prospective CE and NR (PeripheralHI - CentralLO) Whole genome expression screen; Proliferation analysis
Chx10CRE-GFP E10.5 Prospective CE and NR (Mosaic) Genetic epistasis (Cre expression is not affected by SOX2 or β-Catenin)
Abbreviations: CE ciliary epithelium, NE neural retina.
Figure 2 Deletion of Ctnnb1 does not restore neurogenesis to Sox2-mutant cells. Transverse sections of E13.5 control and mutant eyes
were analyzed for restoration of neurogenic fate to Sox2-ablated regions. (A, D, G, J) Ccnd1 mRNA localizes to the central optic cup (OC) of wild-type
controls (A) and Ctnnb1lox(ex2–6)/lox(ex2–6) single-mutants (D) and is maintained in the central OC of Sox2 single-mutants (G) and Sox2/Ctnnb1
double-mutants (J). (B, E, H, K) β-Tubulin III, marking neurons, is expressed in the retinal ganglion cell (RGC) layer of controls (B) and Ctnnb1
single-mutants (E), but its expression is markedly reduced in Sox2 single-mutant (H) and double-mutant (K) cells. (C, F, I, L) Sonic Hedgehog
(Shh) mRNA expression correlates with the pattern of β-Tubulin III staining, and thus is significantly reduced in mutants (I, L) compared with
controls (F, C). Black arrowheads in (C) and (F) indicate the limits of Shh expression. White arrowheads in (C, F, I and L) point to an unaffected
region of Shh expression in the presumptive eyelid. Scale bars: 200 μm.
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Table 2 Differences in the expression patterns of central optic cup progenitor cells (OCPCs) of wild-type, single-mutant
and double-mutant eyes
NR markers Ciliary epithelium markers Optic cup progenitor cell TFs D-Cyclins (protein)
Genotype Hes5 β-Tubulin/
Shh
Msx1 Otx1 BMP4 Zic1 Chx10 Rax Pax6 CyclinD3 CyclinD1
Wild-type expressed expressed absent absent absent absent expressed expressed expressed absent expressed
Sox2-/-;
Ctnnb1-/+
absent absent expressed expressed expressed expressed expressed expressed increased expressed increased
Sox2-/+;
Ctnnb1-/-
expressed expressed absent absent absent absent expressed expressed expressed absent expressed
Sox2-/-;
Ctnnb1-/-
absent absent absent absent absent absent expressed expressed increased expressed increased
Abbreviation: TFs transcription factors.
Heavner et al. Neural Development 2014, 9:27 Page 6 of 18
http://www.neuraldevelopment.com/content/9/1/27Genetic ablation of β-Catenin prevents cell fate conversion
of Sox2-mutant retinas
We next examined single- and double-mutant neonatal
eyes to determine whether removal of Ctnnb1 could res-
cue the NR-to-CE cell fate conversion previously ob-
served in Sox2-mutant eyes [5]. At P0, Sox2 single-
mutant and Sox2/Ctnnb1 double-mutant eyes were
small, and the optic neuroepithelium of both was hypo-
plastic compared with controls (Figure 3A, B and E, F
versus I, J and M, N). To clearly identify mutant cells in
each background, we applied two methods: first we used
an antibody against β-Catenin to distinguish positive
and negative cells (Figure 3B”, E”, H”, K”). Secondly, we
backcrossed all genotypes to reporter mice expressing β-
galactosidase (β-gal) from the ROSA26 locus [43] to
mark recombined cells (Figure 3C”, F”, I”, L”).
Bmp4 and Msx1 were expressed in the presumptive
CE of wild-type controls as expected (Figure 3B, C)
[8,44]. By contrast, Bmp4 and Msx1 were absent from
presumptive CE cells of Ctnnb1 single-mutants, support-
ing the hypothesis that canonical WNT signaling directly
regulates the expression of CE primordium genes
(Figure 3E, F, E’ and F’ arrows). As seen in our previous
study, Bmp4 and Msx1 were ectopically expressed in
Sox2-ablated regions (Figure 3H, I, H’ and I’, area be-
tween closed arrowheads) [5]. This ectopic up-regulation
of Bmp4 and Msx1 occurred in approximately 30 to 60%
of recombined cells based on GFP or β-gal expression.
Strikingly, genetic deletion of Ctnnb1 from these cells
prevented the ectopic expression of Bmp4 and Msx1
(Figure 3K, L, K’, L’ area between closed arrowheads) in
all retinas analyzed (n = 3 per genotype, per stage). We
noted marginal CE gene expression at the periphery of
β-Catenin-positive/Cre-negative regions in double-
mutants (Figure 3 K’, L’ open arrowheads), possibly indi-
cating a signaling center for CE specification at the
edges of NR, as has been reported in the chick OC [45].
We next examined expression of additional NR and
CE markers in control, single-mutant and double-
mutant OCs at P0, and these results are summarized inTable 2. Similar to Bmp4 and Msx1, ectopic expression
of the CE genes Otx1 and Zic1 was rescued in double-
mutants. The pan-OCPC transcription factors Chx10
[42] and Rax [46] were unchanged in all genotypes. Not-
ably, Pax6, which was increased in Sox2 single-mutants
[5], remained so in double-mutants, suggesting that
SOX2 antagonizes Pax6 independently of WNT signal-
ing. Together, these data suggest that SOX2 antagonizes
CE identity, in part through mediation of WNT/β-Ca-
tenin activity.
Ectopic WNT pathway activation in SOX2-expressing cells
results in loss of NR fate
To confirm the notion that up-regulation of the WNT path-
way is sufficient to cause the NR-to-CE fate transformation
observed in Sox2 mutants, we used a complementary ap-
proach, expressing a stable mutant form of Ctnnb1 specific-
ally in NR-committed Sox2-expressing cells. Sox2CreERT2/+
males [47] were crossed with Ctnnb1lox(ex3)/lox(ex3) females,
which were injected with tamoxifen at E11.5 to activate Cre
expression. Analysis of Sox2CreERT2/+;Ctnnb1lox(ex3)/+ mutant
eyes at E15.5 revealed abnormal NR morphology showing
signs of detachment (Figure 4). We observed ectopic areas
of activation of the CM genes Bmp4 and Msx1 (Figure 4D,
E), which corresponded to regions accumulating β-Catenin,
as seen on serial sections (arrowheads, Figure 4G), and
lacking the bipolar cell and photoreceptor marker Otx2
(Figure 4F) [48]. These areas also showed gross reduction
in SOX2 protein (Figure 4I) and Ki67 (Figure 4H), further
suggestive of loss of NR fate and consistent with a reduction
in proliferative capacity in the CE. Of note, not all regions
accumulating β-Catenin activated expression of CE genes;
however, upon close examination, it was evident that SOX2
and Ki67 were excluded from β-Catenin-accumulating cells
(arrows, Figure 4J-O). Taken together, these data suggest
that WNT pathway activation can override establishment
of NR fate even in cells initially expressing Sox2. Despite
WNT activation being a consequence of SOX2 loss, stable
expression of Ctnnb1 resulted in a subsequent reduction
in SOX2 expression.
Figure 3 Deletion of Ctnnb1 prevents the ectopic expression of ciliary epithelium (CE) genes in Sox2-mutant cells. Transverse sections of
P0 eyes were analyzed for CE fate. (A, D, G, J) Low magnification view of β-Catenin/GFP-stained eyes indicates hypoplasia of Sox2 single-mutants
(G) and Sox2/Ctnnb1 double-mutants (J) compared with Ctnnb1lox(ex2–6)/lox(ex2–6) single-mutants (D) and wild-type littermates (A). (B-C”) In situ
hybridization of Bmp4 (C) and Msx1 (D) shows specific expression of these genes in GFP-positive (B”) and β-galactosidase (β-gal)-positive (C”) CE
of wild-type controls. (E-F”) Bmp4 (E) and Msx1 (F) are not expressed in the GFP-positive (E”, arrow) and β-gal-positive (F”, arrow) CE of Ctnnb1
single-mutants. (H-I”) Conversely, Bmp4 (H) and Msx1 (I) are ectopically expressed in the GFP-positive (H”, closed arrowheads) and β-gal-positive
(I”, closed arrowheads) central optic cup (OC) of Sox2 single-mutants. (K-L”) Ectopic expression of Bmp4 (K) and Msx1 (L) is rescued in
the GFP-positive (K”, closed arrowheads) and β-gal-positive (L”, closed arrowheads) central OC of Sox2/Ctnnb1 double-mutants. Open
arrowheads indicate faint expression of CE genes at the periphery of the NR of double-mutants. Boxes in (B-C), (E-F), (H-I) and (K-L) are magnified in ’
and ”. Scale bars: 100 μm.
Heavner et al. Neural Development 2014, 9:27 Page 7 of 18
http://www.neuraldevelopment.com/content/9/1/27Attenuation of WNT signaling does not alter RPC
proliferation
Down-regulation of WNT signaling was not sufficient to
improve Sox2-mutant microphthalmia (Figure 3). More-
over, activation of WNT signaling led to a simultaneous
reduction in both SOX2 and Ki67 expression (Figure 4).
We therefore hypothesized that SOX2 regulation of RPC
proliferation occurs independently of WNT activation.
This contrasts the finding that WNT signaling promotes
proliferation of embryonic stem cell-derived RPCs up-
stream of Sox2 [49]. Alternatively, widespread WNT ac-
tivation in vivo at an early developmental time point(E11.5) may have a different effect than that of WNT ac-
tivation in vitro in differentiating neurons. To analyze
the roles of SOX2 and WNT signaling in RPC prolifera-
tion in vivo, we quantified BrdU incorporation in single-
mutant, double-mutant and control eyes over two hours
following a single injection at E14.5 (Figure 5).
By two-factor analysis of variance (ANOVA), Sox2 de-
letion showed a significant effect on percent BrdU in-
corporation (51.3% and 56.8% for wild-type controls and
Ctnnb1 single-mutants versus 20.3% and 26.9% for Sox2
single-mutants and double-mutants, respectively), F
(1,15) = 114.95, P < 0.001 (Figure 5A). Genetic deletion
Figure 4 (See legend on next page.)
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Figure 4 Expression of an activated mutant form of Ctnnb1 in the neural retina (NR) induces ciliary epithelium (CE)-like cell fate
transformation. Transverse sections of mutant eyes induced with tamoxifen to express Ctnnb1lox(ex3) in Sox2-expressing cells at E11.5 were
analyzed at E15.5. (A-I) In situ hybridization for Bmp4 (A, D) and Msx1 (B, E) shows specific expression of these CE genes in ectopic regions,
which accumulate β-Catenin in serial sections (G). Loss of NR fate is evident through in situ hybridization for Otx2 (F) normally marking the NR
(C). Yellow and white arrowheads indicate two regions of β-Catenin accumulation across the different markers in serial sections (D-I). The cell fate
transformation is accompanied by loss of proliferative capacity as seen by anti-Ki67 immunofluorescence (H) and loss of SOX2 (I). (J-O) Double
immunofluorescence for β-Catenin and Ki67 (J-L) and β-Catenin together with SOX2 (M-O) reveal that areas of β-Catenin accumulation in
induced Sox2CreERT2/+;Ctnnb1lox(ex3)/+ retinas are accompanied by the loss of proliferative capacity and the specific reduction of SOX2 indicating
loss of NR fate. Two representative regions of β-Catenin accumulation are indicated across the three markers with yellow arrows (panels J-O).
Scale bars: 200 μm.
Figure 5 Sox2-ablated optic cup progenitor cells (OCPCs) exhibit Ctnnb1-independent proliferation defects. BrdU incorporation of cycling
cells was quantified in single-mutants, double-mutants and wild-type controls after a single pulse at E14.5, and OCPC proliferation in wild-type
controls and Sox2 single-mutants was assessed at 3 developmental time-points. (A) No significant difference in the BrdU/Ki67 index between
wild-types and Ctnnb1lox(ex2–6)/lox(ex2–6) single-mutants at E14.5 is detected, but Sox2 single-mutants show significantly reduced BrdU incorporation.
There is no significant difference in BrdU incorporation between Sox2 single-mutants and Sox2/Ctnnb1 double-mutants. (B-G) Incorporation of
BrdU and concomitant staining for phospho-Histone-H3 between E14.5 and E18.5. Normal ciliary epithelium (CE) development from E14.5-E18.5 is
characterized by a gradual reduction in BrdU incorporation over time (B-D, white brackets in C and D). In Sox2 single-mutants, the peripheral
BrdU-negative region expands over time (E-G, white brackets in F and G). (H-J) Ki67 is maintained in the peripheral optic cup (OC) of controls at
E14.5 (G) but is increasingly reduced at E16.5 (H) and E18.5 (I). (K-M) Ki67 expression in the peripheral OC of Sox2-mutants is similar to that of
controls at E14.5 (J) but is increasingly reduced in the periphery at E16.5 (K) and E18.5 (L). Insets in (A-F) show GFP staining to indicate where
Cre was expressed. Scale bars: 50 μm.
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P > 0.05. Sox2/Ctnnb1 double-mutants did not show a
significant difference in BrdU incorporation compared
with Sox2 single-mutants, suggesting that β-Catenin-
mediated WNT signaling may not act in synergy with
SOX2 in the regulation of RPC proliferation, F(1,15) =
4.41,P > 0.05. Together, these data demonstrate that re-
moving Ctnnb1 has little effect on RPC proliferation in
both wild-type and Sox2-mutant contexts.
Ablation of SOX2 leads to increased cell cycle time
Cell cycle exit and the onset of neuronal differentiation
are tightly coupled. Given the proliferation and neurogen-
esis defects of the Sox2-mutant OC, we further character-
ized cell cycle dynamics of control and mutant eyes by
examining the patterns of BrdU incorporation, phospho-
Histone-H3 and Ki67 expression in wild-type and Sox2-
mutant eyes over time (E14.5-E18.5; Figure 5B-M). BrdU
incorporation was observed in RPCs from the center to
the periphery of control OCs; however, at E14.5, fewer
cells in the periphery of Sox2-mutant OCs incorporated
BrdU compared with controls (Figure 5E versus B). This
peripheral region of decreased BrdU incorporation ex-
panded centrally at E16.5 and E18.5 (Figure 5F, G versus
C, D). By contrast, at E14.5, there was no difference in
the pattern of Ki67 expression between control and mu-
tant OCs (Figure 5K versus H). However, at E16.5, the
Ki67-depleted peripheral region was expanded in mu-
tants compared with controls (Figure 5L versus I), and
this expansion further increased by E18.5 (Figure 5M
versus J). By P0, the Ki67-negative region was extended
far into the center of the Sox2-mutant OC (Additional
file 4A-C versus D-F, area between arrowheads). Not-
ably, some central Sox2-ablated cells still expressed
Ki67 at P0, as did wild-type CE cells just adjacent to
the NR of control eyes (Additional file 4B, C versus E,
F arrows).
These observations raise two non-mutually exclusive pos-
sibilities: 1) Sox2-mutant cells prematurely exit the cell cycle
and/or 2) increase total cell cycle length in a peripheral-to-
central gradient. To more precisely characterize the cell
cycle dynamics of Sox2-ablated cells, we quantified the
lengths of S-phase (TS) and cell cycle (TC) at E14.5 and
E16.5 by pulse-chase labeling with thymidine analogs
(Figure 6A-J) [50]. At E14.5, there was a marked difference
in the TS of central mutant RPCs compared with controls
(24.08 versus 16.30 hours, respectively, P= 0.0002;
Figure 6K). TC was also increased in mutants compared
with controls (51.84 versus 25.51 hours, respectively, P =
0.00002). At E16.5, there was an additional difference in cell
cycle dynamics within Sox2-mutant RPCs but not within
controls. More peripheral RPCs of mutants appeared to
cycle more slowly than those toward the center of the OC.
We therefore divided the E16.5 mutant OC into 'central'and 'peripheral' bins to quantify the difference in cell cycle
rate between the two regions (Figure 6L). Notably, for cen-
tral RPCs, the difference in TS between control and GFP+
mutant cells was not significant (15.08 versus 15.16 hours,
respectively, P = 0.9), but the difference in TC was significant
(23.68 versus 27.22 hours, respectively, P = 0.007). Moreover,
bothTS and TC were significantly longer in peripheral RPCs
of mutants compared with controls (TS: 19.65 versus
15.08 hours, respectively, P = 0.0002 and TC: 51.44 versus
23.68 hours, respectively, P= 0.002).
Taken together, these findings suggest that Sox2-mu-
tant RPCs increase cell cycle time and exit the cell cycle
in a graded manner from the periphery to the center. At
E16.5, central mutant RPCs appear to be unaffected by,
or perhaps compensate for, loss of SOX2 and progress
through S-phase at the proper rate.
D-type Cyclins are increased in Sox2-mutant cells
Despite losing neural competence, Sox2-mutant RPCs
continue to cycle well after deletion of Sox2. We next
asked how RPC proliferation is supported in the absence
of SOX2. D-type Cyclins are expressed in RPCs and pro-
mote progression through the cell cycle [51-53]. We ex-
amined expression of CyclinD1 and CyclinD3 protein by
immunofluorescence in control and mutant OCs at E16.5
and P0. In control embryos, CyclinD1 was localized to the
prospective NR, with higher levels at the boundary of the
NR and CE and extending into the presumptive CE
(Figure 7A, B arrowheads) as observed in zebrafish [11].
Notably, CyclinD1 protein was increased in some Sox2-
negative (GFP-positive) RPCs (Figure 7D, E arrowheads).
This increase appeared cell-autonomous in regions where
Cre expression was mosaic (Figure 7C, F arrowheads).
CyclinD3 protein was confined to the prospective CE of
controls but expanded into the central OC of mutants
(Figure 7G, H versus J, K). Co-labeling with CyclinD1 and
CyclinD3 indicated that these two proteins, which are nor-
mally mutually exclusive, were aberrantly co-expressed in
some Sox2-depleted cells (Figure 7M-P; arrows) [53].
Sonic Hedgehog (SHH) regulates RPC proliferation in
part through CyclinD1 [54-57]. To address whether an
increase in SHH at E16.5 could explain the increase in
CyclinD1 protein, we analyzed Shh mRNA levels by
microarray and ISH. Shh expression was decreased 4.5-
fold in mutant retinas compared with controls (P =
0.0014), and the decrease was confirmed by ISH
(Figure 7I versus L). The primary source of SHH in the
developing retina is thought to be retinal ganglion cells
(RGCs), as we have also shown by ISH at E13.5 [58]
(Figure 2). Given that Sox2-ablated OCs generate far
fewer RGCs and thus have decreased Shh expression, el-
evated CyclinD1 protein in Sox2-ablated cells is most
likely driven by an additional mitogenic pathway not in-
volving SHH.
Figure 6 Sox2-mutant retinal progenitor cells (RPCs) take longer to complete the cell cycle. TS and TC were quantified in control and Sox2
single-mutant RPCs at E14.5 and E16.5. (A-J) Co-labeling with BrdU and IdU indicates which cells have finished S-phase during the protocol (green
only, arrows) and which cells remain in S-phase (yellow, arrowheads) in wild-type (A-G) and mutant (C-J) optic cups (OCs). (K, L) Both TS and TC
are significantly longer in mutant RPCs compared with controls at E14.5 (K). AT E16.5, TS and TC vary between central and peripheral mutant RPCs
(L). TS is significantly longer in peripheral RPCs of mutants compared with controls. TC is significantly longer in both central and peripheral RPCs
of mutants compared with controls. (E-J) are high power magnifications of (A-D). Scale bars: D (for A-D): 100 μm; J (for E-J): 50 μm.
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and PAX6 signaling
We next queried if aberrant CyclinD1 expression is due to
WNT activation given that Ccnd1 is a major transcrip-
tional target of β-Catenin [59]. To address whether ec-
topic WNT activity drove the increase in D-Cyclins
observed in Sox2-mutant OCs, we examined expression ofD-Cyclins in single-mutant, double-mutant and wild-type
control eyes at P0 (Additional file 5). CyclinD1 was
expressed in GFP-positive central OCPCs in wild-type
and Ctnnb1 single-mutant eyes (Additional file 5A-B, E-F,
I- J). As expected, CyclinD1 protein was increased in cen-
tral RPCs of P0 Sox2 single-mutants (Additional file 5C,
G, K; arrows). Moreover, CyclinD1 remained increased
Figure 7 D-type Cyclins are aberrantly expressed in Sox2-ablated optic cup progenitor cells (OCPCs) at E16.5. Expression of D-Cyclins and Shh
was assayed on transverse sections through E16.5 eyes. (A-F) CyclinD1 protein is increased in GFP-positive/Sox2-ablated cells (C-F arrowheads)
compared with controls (A, B). High power magnification of the boxed area in (E) shows cell-autonomous up-regulation of CyclinD1 (C, F). CyclinD1
protein is also elevated in the peripheral NR of controls (arrowheads in A, B). (G-H, J-K) CyclinD3 is restricted to the peripheral OC/prospective ciliary
epithelium (CE) of controls (G, H, arrowhead) and is ectopically expressed in central mutant OCPCs (box in K), supporting NR-to-CE cell fate conversion.
Note that speckled staining in the inner region of the optic cup visible in (H, K, O, P) is non-specific background. (I, L) Shh mRNA expression is
decreased in central OCPCs of mutants (L) compared with controls (I). (M-P) High power magnification of the boxed area in (K) shows that CyclinD1
and CyclinD3 are aberrantly co-expressed in some Sox2-mutant central OCPCs (arrows in P). Black arrowheads in (I) and (L) indicate the extent of Shh
expression. The boxed regions in (I) and (L) are magnified twice in the inserts in each panel. Scale bars: 50 μm.
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rows), suggesting that retinal CyclinD1 levels are com-
pletely independent of Ctnnb1. CyclinD3 protein was
restricted to the CE of both wild-type and Ctnnb1 single-
mutant eyes at P0, and it was ectopically expressed in the
central OC of Sox2 single-mutants and Sox2/Ctnnb1
double-mutants (Additional file 5M-T). Collectively, these
results suggest that SOX2 antagonizes D-Cyclins in the
OC independently of WNT/β-Catenin signaling.
The paired-box transcription factor PAX6 is crucial for
maintaining RPC proliferation and multipotency [60,61].
Despite increased cell cycle exit and decreased Ccnd1 tran-
scription in Pax6-depleted cells, CyclinD1 protein remained
elevated, suggesting that PAX6 regulates CyclinD1 expres-
sion post-transcriptionally or post-translationally. This study
thus revealed a complex role for PAX6 in the regulation of
RPC proliferation and CyclinD1 expression [62]. To test the
alternative hypothesis, that increased PAX6 protein in the
Sox2-ablated OC was responsible for the elevated CyclinD1,
we genetically decreased Pax6 in Sox2-ablated RPCs using
Pax6Sey/+ (small eye) mice as previously described [5]. The
Pax6Sey/+ allele contains an early nonsense mutation in
the Pax6 locus, resulting in a truncated protein widely
used as a Pax6-null [63,64]. We compared CyclinD1 ex-
pression in Sox2cond/cond;Chx10CreGFP single-mutant OCs
with Sox2cond/cond;Pax6Sey/+;Chx10CreGFP double-mutant
OCs and Pax6Sey/+ single-mutant and wild-type controls
at E14.5 (Additional file 6). As expected, CyclinD1 protein
was elevated in central Sox2 single-mutant cells when
compared with wild-type and Pax6 single-mutant cells
(Additional file 6E, F versus A-D). Moreover, CyclinD1
protein remained up-regulated in Pax6/Sox2 double-
mutant OCPCs in the central OC. Elevated CyclinD1 pro-
tein was therefore independent of PAX6 expression in the
Sox2-mutant OC (Additional file 6G, H).
Collectively, our data indicate that loss of Sox2 in the de-
veloping OC resulted in a prolonged cell cycle and eventual
cell cycle exit. During mid-retinogenesis (E16.5), centrally
located Sox2-mutant OCPCs appeared to cycle at the nor-
mal rate and exhibited WNT- and PAX6-independent in-
creased CyclinD1. By contrast, the NR-to-CE primordium
cell fate conversion observed upon ablation of Sox2 was
regulated by WNT/β-Catenin signaling. The prevention of
ectopic CE/CM gene expression by removal of Ctnnb1
from Sox2-mutant cells, but not of increased D-Cyclin
proteins, supports the conclusion that β-Catenin is a
major regulator of CE fate but not of OCPC proliferation.
Discussion
SOX2 regulates the neurogenic/non-neurogenic boundary
of the retina through modulation of WNT signaling
SOX proteins have been shown to physically interact
with β-Catenin to modulate the expression of WNT tar-
get genes [24,38-40]. The SOX2 HMG domain is notrequired to inhibit β-Catenin-induced gene expression in
osteoblasts, suggesting that SOX2 antagonizes WNT sig-
naling through its C-terminus, most likely via β-Catenin
sequestration [24]. Alternatively, SOX2, distantly related
to the TCF/LEF family of transcription factors, which also
bind DNA via an HMG domain, could compete with
TCF/LEF for direct DNA binding [65].
Our data support a model in which SOX2 and WNT
signaling intersect at the level of target gene expression. It
is still unclear, however, how SOX2 antagonizes CE fate.
Using genetic epistasis analysis, we demonstrated that
SOX2 and canonical WNT signaling coordinate opposing
OC fates (modeled in Additional file 7). Both Sox2 LOF
and Ctnnb1 GOF resulted in expansion of CE at the ex-
pense of NR, which is a direct consequence of elevated
WNT signaling, as we find an up-regulation of WNT re-
sponse in Sox2 LOF mutants. In line with this, Ctnnb1
LOF resulted in partial restoration of NR fates in Sox2
LOF eyes, where CE-specific genes failed to become up-
regulated, demonstrating that regulation of CE identity by
SOX2 is mediated by WNT signaling. However, the
neurogenesis defect observed in Sox2 LOF mutants was
not restored by limiting activation of the WNT pathway,
suggesting a WNT-independent role of SOX2 in the regu-
lation of neurogenic fates. Our data reveal that precise co-
ordination of SOX2 and WNT signaling is necessary to
ensure proper development of the neurogenic retina and
circumjacent CB.
SOX2 regulates the cell cycle independently of the WNT
pathway
Genetic ablation of Sox2 in the OC resulted in pro-
longed RPC cell cycle times. This increase is in line with
a fate transition of the NR to CE, where cells have a lon-
ger cell cycle [4,7]. In the Xenopus OC, SOX2 was found
to be necessary for both proliferation and neural compe-
tence, agreeing with the findings of our study [17].
SOX2 was shown to perform this function downstream
of WNT while also feeding back on the WNT pathway
to inhibit it, thus painting a more complex picture of
WNT-SOX2 interactions in OC development [17,25].
Our findings indicate that even a modest increase in
WNT activity upon SOX2 inactivation is associated with
reduced proliferation. Reduced proliferation following
WNT activation has been seen previously [8,11,66] and
aberrant WNT activity was associated with restricted re-
generative capacity in the planarian Procotyla fluviatilis
[67]. Despite WNT activation in Sox2-mutant OCs, the
cell cycle defect of Sox2-mutant cells was not rescued
through deletion of Ctnnb1 and successful down-
regulation of the WNT pathway. Conversely, expression
of activated Ctnnb1 in Sox2-expressing RPCs promoted
CE fate and reduced Ki67 only after a dramatic loss of
SOX2 in cells accumulating β-Catenin, which was not
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tal evidence thereby supports a model in which SOX2 reg-
ulates RPC proliferation independently of WNT signaling
in the mouse.
The Sox2-mutant phenotype suggests complex regulation
of CyclinD1 by SOX2
It was somewhat surprising that RPCs continued to prolif-
erate well after loss of SOX2. One possible explanation for
this sustained proliferation is that stabilized D-Cyclins
permitted OCPCs to progress through the cell cycle.
These data raise an additional contradiction: increased
Cyclins would not be expected to correlate with the ob-
served increase in cell cycle time and decreased BrdU in-
corporation. Nonetheless, in support of our finding, at
least one other instance of increased CyclinD1 protein
and decreased proliferation has been observed in the OC:
Pax6-ablated OCPCs showed elevated CyclinD1 protein
and increased cell cycle exit. In this context, CyclinD1 was
not sufficient to maintain the proliferation of Pax6-ablated
cells, since the CyclinD1-positive cells did not incorporate
BrdU [62]. Thus, CyclinD1 expression may not indicate
sustained proliferation. Moreover, Sox2-ablated cells
undergo a cell fate transformation from a more prolifera-
tive to a less proliferative cell type (NR-to-CE). The pres-
ence of high CyclinD1 protein at the CM at E16.5
(Figure 7b, arrowhead) raises the possibility that cells nor-
mally undergoing the NR/CE cell fate decision have ele-
vated CyclinD1 levels [68].
The decrease in Ccnd1 mRNA suggests that CyclinD1
transcription is positively regulated by SOX2, as SOX2
has been shown to be capable of transactivating the
Ccnd1 promoter in vitro [39]. The unexpected negative
regulation of CyclinD1 protein may take place through
an alternative cascade influenced by SOX2. In human
embryonic stem cells (ESCs), SOX2 and OCT4 promote
the expression of miR-302, a cluster of 8 microRNAs
expressed in pluripotent cells, and miR-302a post-
transcriptionally represses Ccnd1 [69]. Moreover, OC-
specific ablation of Dicer1, a major mediator of micro-
RNA biosynthesis, resulted in increased CyclinD1 pro-
tein in mouse OCPCs, creating a persistent CM-like
region [70]. Therefore, even with decreased Ccnd1 tran-
scription, CyclinD1 protein could be stabilized upon the
loss of microRNA biosynthesis influenced by the lack of
SOX2.
Lastly, SOX2 could antagonize CyclinD1 via direct regu-
lation of the cell cycle inhibitor p27Kip1, as has been ob-
served in inner pillar cells of the mouse auditory sensory
epithelium [71]. Indeed, p27Kip1 protein was absent in
Sox2-null RPCs (WEH, unpublished observations). In
agreement with this notion, genetic ablation of Sox2 spe-
cifically in the developing pituitary gland led to a severe
reduction in proliferative capacity of pituitary embryonicprecursors, although p27Kip1 expression was elevated ra-
ther than repressed [72].
Canonical WNT signaling acts upstream of BMPs to
specify CE fate
A role for BMP signaling in CE specification has been
demonstrated, although the specific sources of ocular
BMPs are currently unclear [34,35,45,73]. Results from
various studies suggest that the developing lens may in-
struct the peripheral OC margin to become CE [35,73].
However, the CE is correctly specified in the absence of
a lens, suggesting that the lens may be more important
for maintaining CE fate [10,74]. Our data suggest that
WNT signaling within the OC acts upstream of BMP
signaling such that expression of Bmp4/7 and the BMP
target gene Msx1 are lost in Ctnnb1-mutant cells and
are up-regulated with stabilization of the pathway.
The Sox2-deficient OC provides a resource to identify
genes important for CE development
Downstream of BMP and WNT signaling, much of CE de-
velopment remains a mystery. Many of the significantly
up-regulated genes in this study were associated with ion
exchange and secretion (Figure 1). Up-regulation of these
groups of genes is consistent with the function of the CB
to maintain constant intraocular pressure (IOP) through
the active transport of fluid via Na+-K+ exchange pumps
and Cl− channels [30]. Given that the presumptive CB epi-
thelium significantly expands upon Sox2 ablation, our
genome-wide screen may reveal previously unidentified
genes important for the function of the CB.
Conclusions
Our study demonstrates that SOX2 regulates the neuro-
genic boundary of the retina in part through mediation of
canonical WNT signaling, such that genetic removal of
Ctnnb1 from Sox2-mutant eyes partially restores neural
retina cell fate. By contrast, Sox2, but not Ctnnb1, is re-
quired to maintain RPC proliferation. The increase in total
cell cycle time of Sox2-mutant RPCs may explain how
mutations in human SOX2 contribute to microphthalmia.
Methods
Animals
All animal work was carried out in compliance with the
University of North Carolina Institutional Animal Care and
use committee (IACUC) policies and ethical approval by
the Division of Laboratory Animal Medicine (DLAM) at
The University of North Carolina at Chapel Hill. Gener-
ation of the Sox2Cond/+ mouse line was described previously
[16]. Sox2cond/+ and Sox2cond/+;αP0CREiresGFP mice were
maintained on a C57BL/6 J background, and all others de-
scribed in this study were maintained on a mixed back-
ground containing 129/Sv and C57BL/6 J. αP0CREiresGFP
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ter [43], Pax6Sey/+ [64], Ctnnb1lox(ex3)/+ [75] and Sox2CreERT2/+
[47] mice have been previously described. For CreERT2
activation, pregnant dams received a single injection of
tamoxifen totaling 1.5 mg, and simultaneous injection
with 0.75 mg progesterone (both Sigma-Aldrich, St Louis,
MO, USA) to reduce the risk of spontaneous abortion.
Tissue preparation, immunostaining and in situ
hybridization
Immunostaining was performed as previously described
[5]. Additional antibodies used in this study include
CyclinD1 (1:400, Thermo Scientific, Waltham, MA, USA),
CyclinD3 (1:100, Cell Signaling, Beverly, MA, USA), β-
Catenin (1:250, Abcam, Cambridge, MA, USA) and β-
galactosidase (1:10,000 Molecular Probes, Eugene, OR,
USA). Antigen retrieval was used for antibodies against
BrdU, CyclinD3 and phospho-Histone-H3 as previously
described [76]. In situ hybridization was performed on 14-
μm frozen sections as described [5]. The following probes
were used: Bmp4, Msx1, Ccnd1 3’UTR, Shh, Otx2 and
Hes5 (kind gifts from Dr A LaMantia, Dr Y Liu, Dr C
Cepko, Dr E Tucker, Dr JP Martinez-Barbera and Dr E
Anton, respectively). Images were captured on a Leica
inverted microscope (Leica DMIRB, Leica Microsystems
GmbH, Germany) equipped with a Retiga (SRV-1394,
QImaging, BC, Canada) camera or on an Olympus laser
scanning confocal microscope (Olympus Fluoview FV1000,
Olympus America, PA, USA) and processed using Adobe
Photoshop software. Unless otherwise stated, a minimum
of three samples per genotype were analyzed for each assay.
BrdU and IdU labeling
Pregnant dams (E14.5 or E16.5) were injected intraperito-
neally with 120 mg IdU per kg body weight at time (T) 0.
At T = 1.5 hours, dams were injected with 100 mg BrdU
(Sigma B5002, Sigma-Aldrich, St Louis, MO, USA) per kg
body weight. At T = 2 hours, dams were culled and em-
bryos were fixed in cold 4% PFA. A mouse antibody
against IdU and BrdU (BD) detected both thymidine ana-
logs, and a rat antibody specific to BrdU (Serotec, Raleigh,
NC, USA) detected BrdU alone [50].
Cell counting, S-phase and cell cycle measurements
For each eye, a section through the middle of the eyecup
was imaged using an Olympus Fluoview FV1000 confocal
microscope (Olympus America, PA, USA). Four eyes from
separate animals were collected for each genotype, for
each stage. For E16.5 eyes, the prospective NR was divided
into 2 bins (central and peripheral) using Olympus Fluo-
view 2.1c software, totaling to 2 regions per section, cover-
ing the entire prospective retina. Note, for all proliferation
experiments in this study (Figures 5 and 6), we quantified
data for RPCs (central OCPCs) in controls and mutants.Data for prospective CE progenitor cells (peripheral
OCPCs) were too variable to support any reliable conclu-
sions. In wild-type eyes, all proliferating cells were
counted. In mutant eyes, only GFP-positive proliferating
cells were counted (ranges E14.5 1,200 to 2,400 cells per
section, E16.5 1,500 to 3,200 cells per section). At least 3
samples from each genotype were used in the final calcu-
lations at E16.5. For studies at E14.5, we analyzed 3 wild-
type controls, 4 each from single mutant genotypes and 6
double-mutants. To determine the effect of Sox2 and
Ctnnb1 on BrdU index, a two-factor ANOVA was per-
formed. To determine the significance of differences in
cell cycle times between controls and Sox2 single-
mutants, a Student’s t-test was carried out. P-values less
than 0.05 were considered significant, and those less than
0.001 were considered highly significant. The following
formula was used to calculate BrdU index:
BrdU index ¼ BrdUþ cells=Ki67þ cellsð Þ  100
S-phase and cell cycle times were calculated as de-
scribed [50]. The ratio of 'S' cells (BrdU/IdU double-
positive) to 'L' cells (IdU-only) was measured, and the
following formulae were used:
S‐phase length TSð Þ ¼ 1:5  S cells=L cellsð Þ
Cell cycle length TCð Þ ¼ TS
 Ki67 þ cells=S cellsð Þ
Whole-genome expression analysis
Pairs of eyes were enucleated from 6 wild-type (Sox2cond/+
;αP0CREresGFP) and 6 mutant (Sox2cond/cond;αP0CREresGFP)
embryos at E16.5 (for a total of 12 eyes per genotype).
Each pair of eyes was immediately placed in RNA-Later
RNA stabilization solution and stored at 4°C for no longer
than 30 days. RNA was purified using an Ambion (Foster
City, CA, USA) RNaqueous kit following the manufac-
turer’s instructions. Five hundred nanograms of RNA
from each pair of eyes were amplified and biotin-labeled
using an Ambion Illumina (San Diego, CA, USA) Total-
Prep RNA Amplification kit. One and a half micrograms
of labeled cRNA were hybridized to Illumina (San Diego,
CA, USA) mouse WG-6 expression bead chips (six replicate
arrays per genotype, for twelve arrays total). Microarray data
were generated by Expression Analysis (Durham, NC, USA).
Briefly, to detect significant changes in gene expression
between controls and mutants, a permutation analysis for
differential expression (PADE) was performed. PADE re-
peatedly randomly reassigns each sample to one of the
two groups to determine if the calculated difference in
levels of a transcript is non-random. PADE was also used
to estimate the FDR for sets of differentially expressed tran-
scripts. A P-value for each transcript was calculated using a
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discovery rate (FDR) of less than 5%, a P-value of less than
0.05, and a fold change of greater than ±1.6, totaling 2,194
transcripts, were chosen for further analysis. Functional
gene annotation was identified using DAVID [28,29] and po-
tentially affected pathways were determined using Ingenu-
ity Pathway Analysis (Qiagen, Redwood City, CA, USA).Additional files
Additional file 1: Significantly changed optic cup (OC) WNT target
genes. Thirteen known OC WNT target genes were found to be changed at
least 1.47-fold (log ratio of at least ±0.55) in mutant compared with control eyes.
Additional file 2: Functional Annotation of the Sox2-ablated optic
cup (OC) reveals cell fate change. Functional terms significantly
enriched for up-regulated genes (first tab) and down-regulated genes
(second tab) resulting from optic cup-specific ablation of Sox2.
Additional file 3: Chx10CreGFP efficiently ablates Sox2 and Ctnnb1
from the optic cup (OC) without causing increased cell death. The
efficiency of Chx10CreGFP and cell death were assessed in double-mutants
at E14.5. (A-B, D-E) SOX2 and β-Catenin are absent from CreGFP-positive
cells in double-mutants (C,D) compared with controls (A,B). (C,F) Cleaved
Caspase 3 is similar between controls and mutants. Scale bar: 200 μm.
Additional file 4: Sox2-deficient OCPCs prematurely exit the cell
cycle. Cycling cells in neonatal controls and mutants were identified by
Ki67 staining. (A-F) In controls, Ki67 is expressed in RPCs (red in A) and in
some GFP-positive CE cells adjacent to the NR (B-C; arrows) but not in
the most peripheral CE cells (B-C; arrowheads). In mutants, Ki67 is
expressed in centrally located Sox2-ablated RPCs (E-F; arrows) but not in
peripheral Sox2-ablated RPCs (E-F; arrowheads). Boxed areas in (A) and (D)
are magnified in (B-C) and (E-F), respectively. Scale bars: 100 μm.
Additional file 5: Deletion of Ctnnb1 in Sox2-ablated optic cup
progenitor cells (OCPCs) does not rescue increased CyclinD1 or
ectopic expression of CyclinD3. CyclinD1 and CyclinD3 expression
were analyzed in single-mutants, double-mutants and controls at P0.
CyclinD1 is restricted to retinal progenitor cells (RPCs) in controls (A-C)
and Ctnnb1 single-mutants (F-H). CyclinD1 is increased in GFP-positive
cells in the central OC of Sox2 single-mutants (K-M; arrows) and in Sox2/
Ctnnb1 double-mutants (P-R; arrows). CyclinD3 is restricted to the CE of
controls (D, E; arrows) and Ctnnb1 single-mutants (I, J; arrows) and
ectopically expressed in GFP-positive cells in the central OC of Sox2
single-mutants (N, O; arrows) and Sox2/Ctnnb1 double-mutants (S, T;
arrows). Boxed areas in (A, F, K and P) are magnified in (B, C; G, H; L, M;
and Q, R), respectively. Scale bars: 100 μm.
Additional file 6: Reduction of Pax6 in Sox2-ablated optic cup
progenitor cells (OCPCs) does not rescue increased CyclinD1.
CyclinD1 was assayed on transverse sections through the eyes of Sox2
single-mutants, Pax6Sey/+ single-mutants, double-mutants and wild-type controls
at E14.5. (A-D) CyclinD1 is expressed in retinal progenitor cells (RPCs) of controls
(A, B) and Pax6Sey/+ single-mutants (C, D). (E-H) CyclinD1 is increased in central
OCPCs of Sox2 single-mutants (E, F) and Sox2/Pax6Sey/+double-mutants
(G, H). Scale bar: 200 μm.
Additional file 7: Model of how SOX2 and canonical WNT signaling
regulate the neurogenic boundary of the optic cup (OC). OC-specific
genetic ablation of Sox2 or Ctnnb1 results in complementary phenotypes.
(A-D) The boundary between neural retina (NR) (blue) and ciliary
epithelium (CE) (orange) is shifted peripherally in Ctnnb1 single-mutants
(B) compared with controls (A). Conversely, the boundary between NR
and CE is shifted centrally in Sox2 single-mutants such that WNT and
BMP signaling are expanded (C) compared with controls (A). The boundary
between the NR and CE remains centrally shifted in Sox2/Ctnnb1 double-
mutants (D). However, BMP signaling and other classical CE markers fail to
be expressed in this expanded CE-like region. D-type cyclins are increased in
both Sox2 single-mutants and Sox2/Ctnnb1 double-mutants.Abbreviations
ΑΝΟVΑ: analysis of variance; β-gal: β-galactosidase; BAC: bacterial artificial
chromosome; BrdU: bromodeoxyuridine; CB: ciliary body; Ccnd1: CyclinD1;
Ccnd3: CyclinD3; CE: ciliary epithelium; CM: ciliary margin; Ctnnb1: β-Catenin;
E: embryonic day; ESCs: embryonic stem cells; FDR: false discovery rate;
GFP: green fluorescent protein; GOF: gain-of-function; IdU: iododeoxyuridine;
IHC: immunohistochemistry; ISH: in situ hybridization; IOP: intraocular
pressure; LOF: loss-of-function; NR: neural retina; OC: optic cup; OCPC: optic
cup progenitor cell; P: postnatal day; PADE: permutation analysis for
differential expression; PCR: polymerase chain reaction;
PFA: paraformaldehyde; RGC: retinal ganglion cell; RPC: retinal progenitor
cell; Sey: small-eye mutation; Shh: Sonic Hedgehog; TC: cell cycle time;
TGFβ: transforming growth factor beta; TS: S-phase time.
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